Skip to main content

Table 2 Outcomes included in the summary of results.

From: The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials

17-item Hamilton Rating Scale for Depression (HAMD17)
   Total score [24]
   Core subscale (items 1, 2, 3, 7, 8) (not published)
   Maier subscale (items 1, 2, 7, 8, 9, 10) [25]
   Anxiety/Somatization subscale (items 10, 11, 12, 13, 15, 17) [26]
   Retardation subscale (items 1, 7, 8, 14) [27]
   Sleep subscale (items 4, 5, 6) [27]
Montgomery-Asberg Depression Rating scale [28]
Hamilton Anxiety Rating Scale total score [29]
Clinical Global Impression of Severity [26]
Patient Global Impression of Improvement [26]
Visual Analog Scale for pain [30]
   Overall pain severity
   Headaches
   Back pain
   Shoulder pain
   Time in pain while awake
   Interference with daily activities
Somatic Symptom Inventory [31]
   26 Item total score
   28 Item total score (includes 2 additional questions on painful physical symptoms)
Quality of Life in Depression Scale total score [32]